期刊文献+

E-cadher in和MMP-9与胃肠道间质瘤预后的关系 被引量:1

下载PDF
导出
摘要 目的探讨E—cadherin和MMP-9在胃肠道间质瘤(GIST)中的表达与GIST预后的关系。方法收集临床病例资料并进行随访,应用免疫组化s—P法检测E—cadherin和MMP-9在GIST的表达情况,分析不同表达对GIST术后2年复发转移率和5年生存率的影响。结果全组病例E—cadherin和MMP-9的阳性表达率分别为65.38%、55.13%。2年复发转移率和5年生存率分别为31.8%、72.3%。不同E—cadherin和MMP-9表达组5年生存率有显著性差异(P〈0.05),不同表达组2年复发转移率亦有显著性差异(P〈0.05)。结论E—cadherin及MMP-9在胃肠道问质瘤中存在表达,它们之间存在相互作用。它们与GIST的的预后密切相关,可作为预测GIST预后的参考指标。 Objective: To investigate the relationship between the expression of E-cadherin , matrix metalloproteinases-9 and the prognosis of gastrointestinal stromal tumor (GIST) . Methods: To collect the cases and follow up.Immunohistochemical technique was used to investigate the expression of E-cadherin and MMP-9. To investigate the impacts of E-cadherin and MMP-9 on the 2-year recurrence and metastasis rate and 5-year survival rate in patients with GISTs.Results: The positive rate of E-cadherin and MMP-9 were respectively 65.38%. 55.13%.The 2-year recurrence and metastasis rate and 5-year survival rate were 31.8%, 72.3% respectively.To different expression of E-cadherin and MMP-9, There was significiant differences in the 5-year survival rate (P〈0.05) . To different expression of E-cadherin, The differences were significiant (P〈0.05) in the 2-year recurrence and metastasis rate. Conclusion: The expression of E-cadherin and MMP-9 are closely related to the biological behavior of GIST, which may be used as an objective parameter for distinguishing malignant from benign GIST.
作者 刘湘国
出处 《中国保健营养(临床医学学刊)》 2010年第2期5-7,共3页 China Health Care Nutrtion
关键词 胃肠道间质瘤 钙粘蛋白 基质金属蛋白酶 预后 免疫组化 E-cadherin matrix metalloproteinases-9 prognosis Immunohistochemistr
  • 相关文献

参考文献9

  • 1杜春燕,师英强,傅红,赵广法,周烨,蔡国响.胃肠道间质瘤103例预后分析[J].中国实用外科杂志,2007,27(4):297-299. 被引量:49
  • 2Plaat BE, Hollema H, Molenaar WM, et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins[J].J Clin Oncol, 2000, 18: 3211-3220.
  • 3Ng EH,Pollock influencing RE,Munsell MF,et al. Prognostic factors survival in gastrointestinal leiomyosarcomas : implications for surgical management and staging[J].Ann Surg, 1992,215:68-77.
  • 4De Matteo RP, Lewis JJ, Leung D, etal. Two hundred gastrointestinal stormal tumors : recurrence patterns and prognostic factors for survival[J].Ann Surg, 2000, 231: 51-58.
  • 5马大烈,白辰光.胃肠道间质瘤的病理诊断和预后[J].世界华人消化杂志,2006,14(24):2367-2371. 被引量:21
  • 6Fletcher CD, Berman JJ, Corless C. Diagnosis of gastrointestinalstromal tumors : a consensus approach [J]. HumPathol, 2002, 33 (5): 459-465.
  • 7李杰茹,齐凤英.基质金属蛋白酶抑制剂与肿瘤侵袭转移[J].国外医学(肿瘤学分册),2004,31(6):409-412. 被引量:7
  • 8La Rocoa G, Pacci-Minafra I, Marrazzo A, et al. Zymogrophic detection and clinical correlations of MMP- 2 and MMP- 9 in breast cancer sera[J]. Br J Cancer, 2004, 90 (7): 1414.
  • 9Llorens A , Rodrigo I , Lopez - Barcons L , et al. Down regulation of E - cadherin in mouse skin carcinomcells a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinaseexpression[J].Lab Invest , 1998 , 78 (9): 11311.

二级参考文献17

  • 1侯英勇,杨雄华,谭云山,许建芳,王岫南,曾海英,宿杰.阿克苏,高峰,朱雄增.不同部位胃肠道间质瘤免疫组化表达的研究[J].临床与实验病理学杂志,2005,21(2):142-146. 被引量:21
  • 2贺慧颖,项一宁,李燕,钟镐镐,吴秉铨,郑杰.胃肠道间质瘤60例中c-kit和PDGFRA基因突变的检测[J].北京大学学报(医学版),2005,37(3):320-324. 被引量:10
  • 3Chen-Guang Bai,Xiao-Hong Liu,Qiang xie,Fei Feng,Da-Lie Ma.A novel gain of function mutant in C-kit gene and its tumorigenesis in nude mice[J].World Journal of Gastroenterology,2005,11(45):7104-7108. 被引量:6
  • 4贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 5Fletcher CD,Berman JJ,Corless C.Diagnosis of gastrointestinal stromal tumors:a consensus approach[J].Hum Pathol,2002,33(5):459-465.
  • 6Miettinen M,Sobin LH,Sarlomo-Rikala M.Immunohistochemieal spectrum of gastrointestinal stromal tumors at different sites and their differential diagnosis with other tumors with a special reterence to CD117 (KIT)[J].Mod Pathol,2000,13(10),1134-1142.
  • 7Berman J,O'leary TJ.Gastrointestinal stromal tunmor workshop[J].Hum Pathol,2001,32(6):578-582.
  • 8DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231(1):51-58.
  • 9Mudan SS,Colon KC,Woodruff JM,et al.Salvage surgery for patients with recurrent gastrointestinal sarcoma:prognostic factors to guide patient selection[J].Cancer,2000,88(1):66-74.
  • 10Edmonson JH.Contrast of response to dacarbazine,mitomycin,doxorubicin,and cisptatin (DMAP) plus GM-CSF between patients with advanced malignant gastrniutcstinal stromal tumors and patients with other advanced leiomyosarcomas[J].Cancer Invest,2002,20(5-6):605-612.

共引文献73

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部